Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271. / Marthaler, Adele Gabriele; Schmid, Benjamin; Tubsuwan, Alisa; Poulsen, Ulla B.; Engelbrecht, Alexander F.; Mau-Holzmann, Ulrike A.; Hyttel, Poul; Nielsen, Jørgen Erik; Nielsen, Troels Tolstrup; Holst, Bjørn.
I: Stem Cell Research, Bind 16, Nr. 1, 01.2016, s. 180-183.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271
AU - Marthaler, Adele Gabriele
AU - Schmid, Benjamin
AU - Tubsuwan, Alisa
AU - Poulsen, Ulla B.
AU - Engelbrecht, Alexander F.
AU - Mau-Holzmann, Ulrike A.
AU - Hyttel, Poul
AU - Nielsen, Jørgen Erik
AU - Nielsen, Troels Tolstrup
AU - Holst, Bjørn
N1 - Copyright © 2015. Published by Elsevier B.V.
PY - 2016/1
Y1 - 2016/1
N2 - Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease primarily affecting the cerebellum. Very little is known about the molecular mechanisms underlying the disease and, to date, no cure or treatment is available. We have successfully generated bona fide induced pluripotent stem cell (iPSC) lines of SCA2 patients in order to study a disease-specific phenotype. Here, we demonstrate the gene correction of the iPSC line H271 clone 1 where we have exchanged the expanded CAG repeat of the ATXN2 gene with the normal length found in healthy alleles. This gene corrected cell line will provide the ideal control to model SCA2 by iPSC technology.
AB - Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease primarily affecting the cerebellum. Very little is known about the molecular mechanisms underlying the disease and, to date, no cure or treatment is available. We have successfully generated bona fide induced pluripotent stem cell (iPSC) lines of SCA2 patients in order to study a disease-specific phenotype. Here, we demonstrate the gene correction of the iPSC line H271 clone 1 where we have exchanged the expanded CAG repeat of the ATXN2 gene with the normal length found in healthy alleles. This gene corrected cell line will provide the ideal control to model SCA2 by iPSC technology.
KW - Alleles
KW - Ataxin-2
KW - Base Sequence
KW - CRISPR-Cas Systems
KW - Cell Differentiation
KW - Cell Line
KW - Cellular Reprogramming
KW - Genotype
KW - Humans
KW - Induced Pluripotent Stem Cells
KW - Karyotype
KW - Male
KW - Molecular Sequence Data
KW - Plasmids
KW - Sequence Analysis, DNA
KW - Spinocerebellar Ataxias
KW - Transcription Factors
KW - Transfection
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1016/j.scr.2015.12.028
DO - 10.1016/j.scr.2015.12.028
M3 - Journal article
C2 - 27345809
VL - 16
SP - 180
EP - 183
JO - Stem Cell Research
JF - Stem Cell Research
SN - 1873-5061
IS - 1
ER -
ID: 172435912